# UH3 Varenicline for Cannabis Use Disorder

> **NCT03980561** · PHASE2 · COMPLETED · sponsor: **Medical University of South Carolina** · enrollment: 174 (actual)

## Conditions studied

- Cannabis Use Disorder

## Interventions

- **DRUG:** Varenicline
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03980561
- **Lead sponsor:** Medical University of South Carolina
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-01-31
- **Primary completion:** 2023-02-09
- **Final completion:** 2023-12-01
- **Target enrollment:** 174 (ACTUAL)
- **Last updated:** 2024-01-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03980561

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03980561, "UH3 Varenicline for Cannabis Use Disorder". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03980561. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*